ScripFrontline Indian firms appear keen to accelerate product in-licensing deals with foreign companies and these efforts have now evolved from a “supplementary tactic” to a cornerstone of their strategy,
ScripThe recent removal of the Risk Evaluation and Mitigation Strategies (REMS) requirement for approved cellular CAR-T therapies for cancer was lauded as an expansion of the market from the two-in-10 el
ScripApogee Therapeutics has posted positive data from its long-acting antibody, APG777, that showed it reduced symptoms of the inflammatory skin condition atopic dermatitis in a 123-patient Phase II study
Pink SheetUS Food and Drug Administration staff are recommending routine safety monitoring of Merck and Co. ’s HPV vaccine, and Sanofi vaccines for seasonal influenza and dengue, after finding no new safety